How Corporate Sustainability Reporting ‘Just ...

In this episode of the China biopharma English-language podcast, Xu Hu talks about the siRNA area, including possible industry and R&D environment changes for Chinese firms developing these therapies and trends in deals of China-originated siRNA assets this year. Story link: Chin ...  Show more

The Life Sciences Hub Wales supports on oncology and cardiovascular disease technologies which are ideally at TRL6. Improved health outcomes is among the aims of the LSHW as it decides where to place its support. Chris Jones of LSHW explained the rationale to Medtech Insight at B ...  Show more

As the global push for Environmental, Social, and Governance (ESG) practices and sustainability gains momentum, CFOs face the challenge of translating complex mandates into actionable strategies that simultaneously satisfy regulators, investors, and the company's bottom line.< ...

As the global push for ESG and sustainability gains momentum, CFOs find themselves translating complex mandates into actionable strategies that satisfy regulators, investors, and the bottom line alike.

This week: The first in a new state-of-sustainability series, Brendan May, business expert and founder of Robertsbridge, talks with Innovation Forum’s Ian Welsh about the apparent current crossroads for sustainable business and why some companies are ...

We've all got a lot savvier about sustainability in recent years. We know the size of the climate challenge facing the planet. And we know that the planet needs more than statements, green logos and commitments to use the printer less to tackle it. As we all make more sustainable ...  Show more